ACID REDUCER - omeprazole tablet, delayed release 
Aurohealth LLC

----------

Tips for Managing Heartburn

Drug Facts

Active ingredient (in each tablet)

Omeprazole delayed-release tablet 20 mg (equivalent to 20.6 mg omeprazole magnesium USP)

Purpose

Acid reducer

Use

Warnings

Allergy alert:

•   Do not use if you are allergic to omeprazole.
•  Omeprazole may cause severe skin reactions. Symptoms may Include:
      •  skin reddening   •  blisters   •  rash


 If an allergic reaction occurs, stop use and seek medical help right way.

Do not use if you have:

These may be signs of a serious condition. See your doctor.

Ask a doctor before use if you have:

Ask a doctor or pharmacist before use if you are taking a prescription drug.

Acid reducers may interact with certain prescription drugs.

Stop use and ask a doctor if:

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222)  right away.

Directions

14-Day Course of Treatment

Repeated 14-Day Courses (if needed)

Other information

Inactive ingredients

crospovidone, glyceryl monostearate, hydroxypropyl cellulose, hypromellose, magnesium stearate, methacrylic acid and ethyl acrylate copolymer dispersion, microcrystalline cellulose, polyethylene glycol, polysorbate 80, red iron oxide, silicified microcrystalline cellulose, sodium hydroxide, sodium stearyl fumarate, sugar spheres [which contains liquid glucose, starch (maize) and sucrose], talc, titanium dioxide,  triethyl citrate and yellow iron oxide.

Questions?

Call 1-855-274-4122

Distributed by:
AUROHEALTH LLC
279 Princeton-Hightstown Road
East Windsor, NJ 08520

Made in India

Code: TS/DRUGS/22/2009

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg (14 Tablet Bottle)

AUROHEALTH            
NDC 58602-729-05

See current Drug Facts


Omeprazole
Delayed-Release Tablets 20 mg
ACID REDUCER
Treats Frequent Heartburn!
24 HR

14 TABLETS
One 14-day course of treatment
May take 1 to 4 days for full effect
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg (14 Tablet Bottle)


PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg Container Carton Label

AUROHEALTH
NDC 58602-729-05

                                                       Compare to Prilsec OTC®
See current Drug Facts                        Active Ingredient*




Omeprazole Delayed-Release
Tablets 20 mg


ACID REDUCER
Treats Frequent Heartburn!
24 HR

14 TABLETS
One 14-day course of treatment
May take 1 to 4 days for full effect
ACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg Container Carton Label

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg Blister Carton Label

AUROHEALTH
NDC 58602-729-65
                                                                  Compare to Prilosec OTC®
See current Drug Facts                      Active Ingredient*

Omeprazole
Delayed-Release
Tablets 20 mg

ACID REDUCER
Treats Frequent Heartburn!
24 HR

14 (2x7) TABLETS
One 14-day course of treatment
May take 1 to 4 days for full effect
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg Blister Carton Label

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg Container Carton Label 14(1x14) Tablets

AUROHEALTH
NDC 58602-729-01

                                                                                     Compare to Prilosec OTC®
See current Drug Facts                                                       Active Ingredient*

Omeprazole
Delayed-Release
Tablets 20 mg

ACID REDUCER
Treats Frequent Heartburn!
24 HR

14 (1x14) TABLETS
One 14-day course of treatment
May take 1 to 4 days for full effect
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg Container Carton Label 14(1x14) Tablets

ACID REDUCER 
omeprazole tablet, delayed release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58602-729
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OMEPRAZOLE MAGNESIUM (UNII: 426QFE7XLK) (OMEPRAZOLE - UNII:KG60484QX9) OMEPRAZOLE20 mg
Inactive Ingredients
Ingredient NameStrength
CROSPOVIDONE (35 .MU.M) (UNII: 40UAA97IT9)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
HYDROXYPROPYL CELLULOSE (90000 WAMW) (UNII: UKE75GEA7F)  
HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A (UNII: NX76LV5T8J)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POLYETHYLENE GLYCOL 4000 (UNII: 4R4HFI6D95)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
SODIUM STEARYL FUMARATE (UNII: 7CV7WJK4UI)  
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
STARCH, CORN (UNII: O8232NY3SJ)  
SUCROSE (UNII: C151H8M554)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
HYDROXYPROPYL CELLULOSE (45000 WAMW) (UNII: 8VAB711C5E)  
HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  
Product Characteristics
ColorPINKScoreno score
ShapeRECTANGLE (Oblong) Size14mm
FlavorImprint Code Z;69
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58602-729-051 in 1 CARTON06/06/2018
114 in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:58602-729-612 in 1 CARTON06/06/2018
214 in 1 BOTTLE; Type 0: Not a Combination Product
3NDC:58602-729-623 in 1 CARTON06/06/2018
314 in 1 BOTTLE; Type 0: Not a Combination Product
4NDC:58602-729-652 in 1 CARTON06/06/2018
4NDC:58602-729-647 in 1 BLISTER PACK; Type 0: Not a Combination Product
5NDC:58602-729-011 in 1 CARTON06/06/2018
514 in 1 BLISTER PACK; Type 0: Not a Combination Product
6NDC:58602-729-022 in 1 CARTON06/06/2018
614 in 1 BLISTER PACK; Type 0: Not a Combination Product
7NDC:58602-729-033 in 1 CARTON06/06/2018
714 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20687706/06/2018
Labeler - Aurohealth LLC (078728447)
Establishment
NameAddressID/FEIBusiness Operations
Aurobindo Pharma Limited650381903ANALYSIS(58602-729) , MANUFACTURE(58602-729)

Revised: 11/2023
Document Id: 35a88ff7-5830-4d37-bc76-1cce55f61ab1
Set id: fde12bf8-3e3b-4813-a8c4-4385e7de8204
Version: 10
Effective Time: 20231129
 
Aurohealth LLC